James E. Flynn - Possible Members of 10% Group, 10%+ Owner at Bicara Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Possible Members of 10% Group, 10%+ Owner
Stock Symbol
BCAX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James E. Flynn since 4/23/2024

Holdings reported by James E. Flynn for Bicara Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 898K $11.9M $13.24 Sep 17, 2024 Through Deerfield Partners, L.P.
Common Stock 898K $11.9M $13.24 Sep 17, 2024 Through Deerfield Private Design Fund V, L.P.
Series C Preferred Stock 0 Sep 17, 2024 Through Deerfield Partners, L.P. Common Stock
Series C Preferred Stock 0 Sep 17, 2024 Through Deerfield Private Design Fund V, L.P. Common Stock

Transactions reported by James E. Flynn for Bicara Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.